Valuation Amarin Corporation plc

Stocks

Real-time Estimate Cboe BZX Other stock markets 23:20:29 06/07/2026 +04			5-day change	1st Jan Change
15.70 ^USD	-4.06%		-1.63%	+12.22%

07-02	European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading	MT
07-01	Amarin Corporation plc Reaffirms the Proven Guideline-Recommended Role of Vascepa (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,333	488.6	355.2	199.5	290.2	343.3	-	-
Change	-	-63.35%	-27.3%	-43.84%	45.45%	18.3%	-	-
Enterprise Value (EV) ¹	1,114	270.4	156	78.46	155.5	169.4	155.8	151.3
Change	-	-75.72%	-42.33%	-49.69%	98.19%	8.94%	-8.04%	-2.9%
P/E	169x	-4.65x	-5.8x	-2.43x	-155x	-468x	298x	252x
PBR	2x	0.82x	0.64x	0.41x	-	-	-	-
PEG	-	0x	0.1x	-0.1x	1.6x	7.7x	-1x	13.9x
Capitalization / Revenue	2.29x	1.32x	1.16x	0.87x	1.36x	1.88x	1.78x	1.82x
EV / Revenue	1.91x	0.73x	0.51x	0.34x	0.73x	0.93x	0.81x	0.8x
EV / EBITDA	44.9x	-5.69x	-2.31x	-0.86x	-3.1x	-6.62x	-7.56x	-5.36x
EV / EBIT	46x	-3.64x	-2.31x	-0.85x	-3.1x	-6.62x	-7.56x	-5.36x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.4	-5.2	-3	-4	-0.09	-0.035	0.055	0.065
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	583.2	369.2	306.9	228.6	213.6	182.2	192.9	188.4
EBITDA ¹	24.81	-47.5	-67.43	-91.7	-50.17	-25.57	-20.61	-28.21
EBIT ¹	24.22	-74.26	-67.59	-91.8	-50.17	-25.58	-20.61	-28.21
Net income ¹	7.729	-105.8	-59.11	-82.18	-38.8	-15.02	22.13	27.06
Net Debt ¹	-219.5	-218.2	-199.3	-121	-134.7	-173.9	-187.5	-192
Reference price ²	67.40	24.20	17.40	9.70	13.96	16.37	16.37	16.37
Nbr of stocks (in thousands)	19,781	20,191	20,415	20,567	20,793	20,969	-	-
Announcement Date	01/03/22	01/03/23	29/02/24	12/03/25	25/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
AMARIN CORPORATION PLC	-467.71x	0.93x	-6.62x	-	343M
ARGENX SE	35.82x	9.04x	28.05x	0.05%	59.1B
WUXI APPTEC CO., LTD.	20.71x	6.39x	13.83x	1.45%	55.19B
BIONTECH SE	-19.36x	4.94x	-8.63x	-.--%	24.67B
INSMED INCORPORATED	-42.26x	14x	-40.82x	-.--%	24.19B
WUXI BIOLOGICS (CAYMAN) INC.	24.52x	4.85x	12.6x	-.--%	19.69B
GENMAB A/S	24.5x	4.84x	16.04x	-.--%	17.56B
PHARMAESSENTIA CORPORATION	48.53x	19.97x	52.67x	0.06%	16.22B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-520.97x	35.77x	-3987.51x	-.--%	14.84B
EXELIXIS, INC.	17.56x	5.1x	11.91x	-.--%	14.04B
Average	-87.87x	10.58x	-390.85x	0.17%	24.58B
Weighted average by Cap.	-17.01x	9.98x	-229.37x	0.34%